Navigation Links
Synteract Hosting CDISC Classes on Regulatory Data Standards, Feb. 21-24, in California
Date:2/17/2012

SAN DIEGO, Feb. 17, 2012 /PRNewswire/ -- Synteract, Inc., a full-service contract research organization (CRO), will be hosting limited registration training classes for CDISC, a global, non-profit organization that has established standards to support the acquisition, exchange, submission and archive of clinical research data. The classes will be held Feb. 21-24, 2012 at Synteract's Carlsbad, Calif., headquarters.

(Logo: http://photos.prnewswire.com/prnh/20111108/MM02925LOGO)

CDSIC collaborates with CROs, including Synteract, to develop uniform data standards for clinical trials. Synteract has provided feedback and industry expertise to CDISC during this process as well as assistance with creating uniform data sets that meet the needs of CROs.  Synteract, in turn, uses its knowledge of regulatory requirements and standards to guide clients.

The classes will cover CDSIC standards and are appropriate for data management and biostatistics professionals in biotech and pharma companies. The training will be conducted by CDISC teachers and a class list and registration are available on CDISC's website. Synteract will also be hosting classes for CDISC Aug. 21-24, 2012 at its North Carolina office.

"Synteract is pleased to support CDISC's mission to improve medical research through platform-independent data standards. Working with CDISC places Synteract at the forefront of industry standards, which we can then pass onto our clients to guide them in the drug development process and ensure data is collected accurately from the start," explained Stewart Bieler, chief operating officer at Synteract. 

Synteract is also assisting with CDASH, a volunteer initiative CDISC began to create a global library of standardized data sets. Synteract currently has three employees contributing to the CDASH project.

About Synteract, Inc. (www.synteract.com)

Synteract is a full-service contract research organization with a successful 17-year track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development.  With its "Shared Work – Shared Vision" philosophy Synteract provides customized Phase I through IV services collaboratively and cost effectively to ensure on-time delivery of quality data so clients get to decision points faster. Headquartered in California, with offices in North Carolina and the Czech Republic, Synteract delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, cardiovascular, respiratory and ophthalmology. 

CONTACT:

Rachel Hutman
Clearpoint Agency, for Synteract
Rachel@clearpointagency.com
760-230-2424

 

 

 


'/>"/>
SOURCE Synteract, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Former Synteract CEO Unveils Non-Profit Contract Research Organization, PHACT, to Help Eliminate Neglected Diseases in Developing Countries
2. Synteract Releases SynCapture Version 1.5 of Its Hybrid Electronic Data Capture (EDC) System
3. National Data Center Hosting Provider, CoreLink Data Centers, to Present at HIMSS 2012
4. HITECH Act Puts Security of Electronic Medical Records in Hands of Hosting Providers
5. Manhattans Physicians Group Selects ITelagen for Hosting and Management of EHR
6. Aprima and MednetwoRx Partner to Provide Electronic Health Records and Remote Hosting Option to Physician Practices
7. DATATRAK Receives CDISC Registered Solutions Provider Status
8. Max Neeman International Expands Data Management Services with Conversion Into CDISC Standard Data Model
9. MedNet Solutions ENLIGHTEN Receives CDISC ODM Certification
10. Reportlinker Adds Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS
11. Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
(Date:6/23/2016)... 2016 The vast majority of dialysis patients ... Treatments are usually 3 times a week, with treatment ... travel time, equipment preparation and wait time.  This regimen ... for patients who are elderly and frail.  Many elderly ... rehabilitation centers for some duration of time. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... Viejo, California (PRWEB) , ... June 26, 2016 , ... ... Final Cut Pro X. , "Film editors can give their videos a whole new ... said Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
Breaking Medicine News(10 mins):